Pink Sheet editors discuss new potential regulations that would expand the agency’s ability to release complete response letters and further limit DTC advertising, as well as a potential FDA senior leadership reorganization.
Pink Sheet editors discuss new potential regulations that would expand the agency’s ability to release complete response letters and further limit DTC advertising, as well as a potential FDA senior leadership reorganization.